Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

How to Increase Engagement During Virtual Events

Tip #1 - How can you take your online presentations to the next level? Check out the full list of top 10 tips to increase engagement during virtual events: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/

Impetus Digital

- PMLiVE

The Age of Diversity, Equality and Inclusion

By Danny Buckland

- PMLiVE

Takeda’s Exkivity receives NICE recommendation for rare form of lung cancer

Patients with EGFR Exon20ins+ NSCLC make up approximately 2% of NSCLC cases

- PMLiVE

Roche’s high-throughput monkeypox test approved for emergency use by FDA

The tests will be conducted on the company’s 6800/8800 cobas systems

- PMLiVE

NHS England gives GPs direct access to cancer tests to speed up diagnosis

From November, GP teams can directly order CT scans, ultrasounds or brain MRIs

- PMLiVE

FDA advisory committee recommends Ardelyx’s Xphozah for chronic kidney disease

The phase 3 trials supporting the submission met all primary and key secondary endpoints

- PMLiVE

University of Birmingham to launch type 1 diabetes trial for at-risk children

Blood tests will identify those deemed most likely to develop the condition

- PMLiVE

Adopting a holistic approach in crafting a product’s value story: utilising HEOR and RWE throughout the product life cycle

By Gary Schneider, Koen Degeling and Kathy Belk

- PMLiVE

ORIGINS INSIGHTS EVOLVES INTO PATIENT SPECIALIST AGENCY

Deeper focus on patient engagement across the pharma/biotech product lifecycle

Origins – The Patient Focused Specialists

- PMLiVE

Mark Corbett explains why Origins is evolving

Resonant Group Chief Innovation Officer, Mark Corbett has released a video explain why Origins is evolving from a Patient Insights agency to a Patient Focused Specialist agency.

Origins – The Patient Focused Specialists

- PMLiVE

Moderna’s bivalent Omicron-targeting boosters show superiority to original COVID-19 vaccine

Both boosters produced a better immune response against Omicron BA.4/BA.5 subvariants

- PMLiVE

Roche enters into second collaboration with Jnana to address complex drug targets

The Boston-based biotech will receive an upfront payment of $50m

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links